Literature DB >> 8566960

Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain.

E Holder1, M Maeda, R D Bies.   

Abstract

Dystrophin mRNA transcripts from the P (Purkinje) promoter were shown to be differentially expressed in human skeletal muscle, heart, and brain. The expression pattern was characteristic of tissue type and developmental stage. Polymerase chain reaction (PCR) analysis of the P promoter transcripts in adult skeletal muscle and adult brain identified two alternatively spliced sequences, one that encodes a full-length dystrophin mRNA and a second that transcribes a termination codon 27 nucleotides (8 amino acids) after the ATG initiation site. Alternative splicing of this truncated coding transcript was developmentally regulated, and it was expressed as the major form in adult cortical brain and adult heart. The biological significance of this peptide remains unclear. The full-length transcript was the major form in fetal cortical brain and adult skeletal muscle. Ribonuclease protection assay demonstrated that as much as 20% of dystrophin transcription in normal adult skeletal muscle was derived from the full-length transcript from the P promoter. In contrast, adult heart did not express significant levels of P promoter derived transcripts. Thus, transcripts from the P promoter were found to be developmentally regulated in the brain, and its activity was differentially expressed in skeletal versus cardiac muscle tissues. These data show that the P promoter transcript displays a broader scope of expression, regulation, and complexity than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566960     DOI: 10.1007/bf02265272

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Cell and fiber-type distribution of dystrophin.

Authors:  E P Hoffman; M S Hudecki; P A Rosenberg; C M Pollina; L M Kunkel
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

2.  An alternative dystrophin transcript specific to peripheral nerve.

Authors:  T J Byers; H G Lidov; L M Kunkel
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

3.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue.

Authors:  M S Mahendroo; C R Mendelson; E R Simpson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Gene deletions in X-linked muscular dystrophy.

Authors:  M Lindlöf; A Kiuru; H Kääriäinen; H Kalimo; H Lang; H Pihko; J Rapola; H Somer; M Somer; M L Savontaus
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

6.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

7.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

8.  Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy.

Authors:  K Yoshida; S Ikeda; A Nakamura; M Kagoshima; S Takeda; S Shoji; N Yanagisawa
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

9.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.

Authors:  C A Feener; M Koenig; L M Kunkel
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

10.  A novel dystrophin isoform is required for normal retinal electrophysiology.

Authors:  V N D'Souza; T M Nguyen; G E Morris; W Karges; D A Pillers; P N Ray
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

View more
  21 in total

1.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

2.  Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Hiroyuki Awano; Emma Tabe Eko Niba; Masafumi Matsuo
Journal:  Hum Genet       Date:  2015-07-08       Impact factor: 4.132

3.  The dystrophin gene and cognitive function in the general population.

Authors:  Dina Vojinovic; Hieab H H Adams; Sven J van der Lee; Carla A Ibrahim-Verbaas; Rutger Brouwer; Mirjam C G N van den Hout; Edwin Oole; Jeroen van Rooij; Andre Uitterlinden; Albert Hofman; Wilfred F J van IJcken; Annemieke Aartsma-Rus; GertJan B van Ommen; M Arfan Ikram; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

4.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.

Authors:  E A Burton; J M Tinsley; P J Holzfeind; N R Rodrigues; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo.

Authors:  John C W Hildyard; Abbe H Crawford; Faye Rawson; Dominique O Riddell; Rachel C M Harron; Richard J Piercy
Journal:  Wellcome Open Res       Date:  2020-07-20

6.  Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype.

Authors:  Ouarda Taghli-Lamallem; Takeshi Akasaka; Grant Hogg; Uri Nudel; David Yaffe; Jeffrey S Chamberlain; Karen Ocorr; Rolf Bodmer
Journal:  Aging Cell       Date:  2008-01-23       Impact factor: 9.304

Review 7.  Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy.

Authors:  Christine Péladeau; Bernard J Jasmin
Journal:  RNA Biol       Date:  2020-11-19       Impact factor: 4.652

8.  Ordered disorder of the astrocytic dystrophin-associated protein complex in the norm and pathology.

Authors:  Insung Na; Derek Redmon; Markus Kopa; Yiru Qin; Bin Xue; Vladimir N Uversky
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Knockdown of dystrophin Dp71 impairs PC12 cells cycle: localization in the spindle and cytokinesis structures implies a role for Dp71 in cell division.

Authors:  Marcela Villarreal-Silva; Federico Centeno-Cruz; Rocío Suárez-Sánchez; Efraín Garrido; Bulmaro Cisneros
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

Review 10.  Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling.

Authors:  Albano C Meli; Vladimir Rotrekl; Barbora Svobodova; Sarka Jelinkova; Martin Pesl; Deborah Beckerová; Alain Lacampagne
Journal:  Pflugers Arch       Date:  2021-06-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.